---
title: "Mr Andrew Nwachukwu Aghadiuno — Ownership Dossier"
canonical: https://whiteintel.dev/entity/fe473d3e-7535-4519-8123-e482ba28e9f2
json: https://whiteintel.dev/api/public/dossier/fe473d3e-7535-4519-8123-e482ba28e9f2
identifier: psc:OqbUEtiVwnfhf89TIppkh0khYVw
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Mr Andrew Nwachukwu Aghadiuno

**Type:** Person  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `psc:OqbUEtiVwnfhf89TIppkh0khYVw`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/fe473d3e-7535-4519-8123-e482ba28e9f2  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/fe473d3e-7535-4519-8123-e482ba28e9f2  

## Ownership & control

### Holdings / subsidiaries

- **JULES PHARMA LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/66475e2c-e69c-5c98-8dd8-9eceb82ec065

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Mr Andrew Nwachukwu Aghadiuno**. Human view: https://whiteintel.dev/entity/fe473d3e-7535-4519-8123-e482ba28e9f2 · Structured JSON: https://whiteintel.dev/api/public/dossier/fe473d3e-7535-4519-8123-e482ba28e9f2._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._